Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day)
U.S. FDA approves new one pill, once-daily AUSTEDO XR tablets AUSTEDO XR offers more flexibility with the most once-daily doses of any vesicular monoamine transporter 2 inhibitor for effective...
United States Dell Faulkingham Rakesh Jain Clin Psychopharmacol National Institute Of Mental Health Texas Tech University School Of Medicine
Source: marketscreener.com